Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Stem Cell Culture01:17

Stem Cell Culture

6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Adult Stem Cells01:33

Adult Stem Cells

33.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Integrated metabolomic profiling reveals metabolomic responses by epicardial and myocardial stromal cells to ischemia.

Metabolomics : Official journal of the Metabolomic Society·2026
Same author

Collagen-Enriched Immunomodulatory Hydrogel for Tendon Regeneration.

Gels (Basel, Switzerland)·2026
Same author

Healing mechanisms of Galectin-1 in the ischemic heart.

Cell biochemistry and biophysics·2026
Same author

Contemporary Operative Trends and Outcomes of Laparoscopic and Robotic Heller Myotomy Using a Large National Database.

The American surgeon·2025
Same author

Inter-hospital variation in transfusion practices for severe trauma.

Injury·2025
Same author

Outcomes and costs in splenectomy after failed splenic arterial embolization for blunt splenic injury.

Surgery open science·2025
Same journal

The potential anticancer effect of Jasonia montana against hepatocellular carcinoma.

Molecular biology reports·2026
Same journal

ATP5F1B promotes breast cancer progression through ERK associated metabolic reprogramming.

Molecular biology reports·2026
Same journal

GATA binding protein 4: Emerging role in liver development and diseases.

Molecular biology reports·2026
Same journal

From adhesion to gene regulation: tea tree essential oil suppresses Uropathogenic Escherichia coli colonization while triggering csgA-mediated biofilm stress paradox.

Molecular biology reports·2026
Same journal

Selective modulation of IL-6/JAK/STAT-related signaling under redox-shift conditions by luteolin.

Molecular biology reports·2026
Same journal

TYK2 signaling as a molecular bridge between cytokine storm and chronic inflammation: therapeutic implications of deucravacitinib.

Molecular biology reports·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

6.8K

心脏衍生的内源性干细胞.

Keiko Inouye1, Garrison White1, Sadia Khan1

  • 1Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, 91766-1854, USA.

Molecular biology reports
|September 10, 2025
PubMed
概括
此摘要是机器生成的。

常驻的心脏衍生性树皮细胞 (CSCs) 显示出损伤后心脏修复的前景. 本综述探讨了各种CSC类型及其对再生心脏病学的潜力,强调了临床应用的领域.

关键词:
心脏再生的心脏再生心脏衍生性树皮细胞来自心脏.心肌梗塞的心脏病发作居民干细胞是干细胞的常驻体.

更多相关视频

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.2K
Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

7.8K

相关实验视频

Last Updated: Jan 18, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

6.8K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.2K
Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

7.8K

科学领域:

  • 心血管研究研究心血管研究
  • 再生医学是一种再生医学.
  • 干细胞生物学 干细胞生物学

背景情况:

  • 再生心脏病学旨在治愈缺血性心脏损伤.
  • 干细胞疗法显示出潜力,但缺乏理想的来源.
  • 内源性心脏衍生性树皮细胞 (CSCs) 提供治疗优势.

研究的目的:

  • 审查各种内源性CSCs在心脏修复方面的治疗潜力.
  • 检查CSC表型及其在愈合机制中的作用.
  • 确定改善CSC转化到临床实践的领域.

主要方法:

  • 审查关于内源性CSCs的新兴研究.
  • 分析CSC的分化,膜信号和再生能力.
  • 检查特定的CSC亚型 (例如c-kit+,Sca-1+,心脏球衍生细胞).

主要成果:

  • CSCs具有天生的分化潜力,特别是在心肌细胞 (CM) 中.
  • 细胞内核细胞通过血管新生,膜信号和细胞补充促进心脏愈合.
  • 存在多种CSC表型,每个都有独特的再生特性.

结论:

  • 内源性CSCs代表了再生心脏病学的有前途的细胞来源.
  • 需要进一步研究CSC的克隆原性和转化潜力.
  • 优化CSC应用对于临床心脏管理至关重要.